Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Cell Death and Differentiation
|
April 13, 2023
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
Ethan L Morgan, Tiffany Toni, Ramya Viswanathan, et al.
Scientific Reports
|
July 29, 2025
Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma
Bryce Hambach, Anhelina Bilokon, John Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2009
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer
Carter Van Waes, Clint T Allen, Deborah Citrin, et al.
Oncotarget
|
February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Paul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Journal for Immunotherapy of Cancer
|
May 5, 2019
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis
Clint T Allen, Sunmin Lee, Scott M Norberg, et al.
Science Translational Medicine
|
October 25, 2023
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis
Scott M Norberg, Ke Bai, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer
Francisco G Pernas, Clint T Allen, Mary E Winters, et al.
The Oncologist
|
March 29, 2025
Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection
Jason M Redman, Renee N Donahue, Seth J Steinberg, et al.
Frontiers in Immunology
|
August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis
Nozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
The Lancet. Respiratory Medicine
|
January 24, 2025
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
Scott M Norberg, Janet Valdez, Scott Napier, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Cell Death and Differentiation
|
April 13, 2023
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
Ethan L Morgan, Tiffany Toni, Ramya Viswanathan, et al.
Scientific Reports
|
July 29, 2025
Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma
Bryce Hambach, Anhelina Bilokon, John Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2009
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer
Carter Van Waes, Clint T Allen, Deborah Citrin, et al.
Oncotarget
|
February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Paul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Journal for Immunotherapy of Cancer
|
May 5, 2019
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis
Clint T Allen, Sunmin Lee, Scott M Norberg, et al.
Science Translational Medicine
|
October 25, 2023
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis
Scott M Norberg, Ke Bai, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer
Francisco G Pernas, Clint T Allen, Mary E Winters, et al.
The Oncologist
|
March 29, 2025
Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection
Jason M Redman, Renee N Donahue, Seth J Steinberg, et al.
Frontiers in Immunology
|
August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis
Nozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
The Lancet. Respiratory Medicine
|
January 24, 2025
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
Scott M Norberg, Janet Valdez, Scott Napier, et al.
Page
of 11